Impact of CYP2C9 and VKORC1 polymorphism on warfarin response during initiation of therapy

Zhonghua xin xue guan bing za zhi

Volumn 39, Issue 10, 2011, Pages 929-935

  Liu, Yuan ^a   Zhong, Shi long ^a   Tan, Hong hong ^a   Yang, Min ^a   Fei, Hong wen ^a   Yu, Xi yong ^a   Lin, Shu guang ^a  

^a GUANGDONG PROVINCIAL PEOPLE'S HOSPITAL   (China)

Author keywords

[No Author keywords available]

Indexed keywords

ANTICOAGULANT AGENT; CYTOCHROME P450 2C9; MIXED FUNCTION OXIDASE; UNSPECIFIC MONOOXYGENASE; VITAMIN K EPOXIDE REDUCTASE; WARFARIN;

AGED; BLEEDING; GENE; GENE FREQUENCY; GENE LINKAGE DISEQUILIBRIUM; GENETIC VARIABILITY; GENETICS; GENOTYPE; HUMAN; INTERNATIONAL NORMALIZED RATIO; SINGLE NUCLEOTIDE POLYMORPHISM;

AGED; ANTICOAGULANTS; ARYL HYDROCARBON HYDROXYLASES; CYTOCHROME P-450 CYP2C9; GENE FREQUENCY; GENES; GENETIC VARIATION; GENOTYPE; HEMORRHAGE; HUMANS; INTERNATIONAL NORMALIZED RATIO; LINKAGE DISEQUILIBRIUM; MIXED FUNCTION OXYGENASES; POLYMORPHISM, SINGLE NUCLEOTIDE; VITAMIN K EPOXIDE REDUCTASES; WARFARIN;

EID: 84899623426     PISSN: 02533758     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (0)